Lipocine Inc Share Price Today: Live Updates & Key Insights
Lipocine Inc share price today is $7.1, up -2.19%. The stock opened at $7.31 against the previous close of $7.31, with an intraday high of $7.31 and low of $6.91.
Lipocine Inc Share Price Chart
Lipocine Inc
Lipocine Inc Share Price Performance
Lipocine Inc Institutional Holdings
Lipocine Inc Market Status
Lipocine Inc Fundamentals
Market Cap 52.19 M
PB Ratio 3.6858
PE Ratio 0.0
Enterprise Value 38.43 M
Total Assets 17.01 M
Volume 79353
Lipocine Inc Company Financials
About Lipocine Inc & investment objective
Company Information Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression; LPCN 1148, a prodrug of testosterone and testosterone laurate that has completed a Phase 2 trial for the management of decompensated cirrhosis; LPCN 1107, an oral hydroxy progesterone caproate product that has completed a Phase 2 trial for the prevention of recurrent preterm birth; LPCN 1144, an oral prodrug of bioidentical testosterone that has completed a Phase 2 trial for pre-cirrhotic non-alcoholic steatohepatitis; and LPCN 2401, an oral formulation comprising a proprietary anabolic androgen receptor agonist that is in a Phase 2 trial to manage incretin mimetic use in obesity management. In addition, the company is developing LPCN 2201, an oral brexanolone formulation that has completed a Phase 1 trial for major depressive disorders; LPCN 2203, an oral candidate that has completed a Phase 1 trial for management of essential tremor; and LPCN 2101, a neuroactive steroids (NAS) candidate that has completed a Phase 1 trial for drug-resistant epilepsy and women with epilepsy. The company's products focus on neurological and psychiatric central nervous system (CNS) disorders, liver disease, and hormone supplementation in the United States. It has a collaboration with Verity Pharmaceuticals, Inc. to develop and commercialize TLANDO; and TLANDO XR (LPCN 1111), a once-daily oral product candidate that has completed a Phase 2 trial for testosterone replacement therapy. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
Organisation Biotechnology
Employees 14
Industry Biotechnology
CEO Dr. Mahesh V. Patel Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Lipocine Inc FAQs
What is the share price of Lipocine Inc today?
The current share price of Lipocine Inc is $7.1.
Can I buy Lipocine Inc shares in India?
Yes, Indian investors can buy Lipocine Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Lipocine Inc shares in India?
You can easily invest in Lipocine Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Lipocine Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Lipocine Inc.
Can I buy fractional shares of Lipocine Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Lipocine Inc?
Lipocine Inc has a market cap of $52.19 M.
In which sector does Lipocine Inc belong?
Lipocine Inc operates in the Biotechnology sector.
What documents are required to invest in Lipocine Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Lipocine Inc?
The PE ratio of Lipocine Inc is N/A and the PB ratio is 3.69.